Testing effectiveness (Phase 2)Active Not RecruitingNCT05669482
What this trial is testing
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
Who this might be right for
KRAS Activating MutationMetastatic CancerPancreas Cancer+2 more
Verastem, Inc. 40